Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 107,953 | 64,069 | 23,275 | 71,410 | 36,566 |
| Depreciation Amortization | 28,316 | 18,865 | 9,430 | 32,881 | 23,738 |
| Income taxes - deferred | -11,943 | -3,359 | -1,746 | -17,818 | -18,701 |
| Accounts receivable | -4,752 | -3,658 | -6,979 | -43,075 | -37,610 |
| Accounts payable and accrued liabilities | -3,232 | -7,679 | -4,534 | 10,820 | 623 |
| Other Working Capital | 26,467 | -1 | -8,647 | -37,324 | -44,978 |
| Other Operating Activity | 26,122 | 27,823 | 21,126 | 126,706 | 128,314 |
| Operating Cash Flow | $168,931 | $96,060 | $31,925 | $143,600 | $87,952 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -468 | -209 | -199 | -231 | -138 |
| Purchase Of Investment | N/A | N/A | N/A | -13,465 | -13,465 |
| Other Investing Activity | 0 | 0 | 0 | -279,806 | -241,581 |
| Investing Cash Flow | $-468 | $-209 | $-199 | $-293,502 | $-255,184 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 148,531 | 144,553 | 142,522 | 2,792 | 2,099 |
| Other Financing Activity | -12,299 | -2,347 | -1,473 | -13,649 | -12,291 |
| Financing Cash Flow | $136,232 | $142,206 | $141,049 | $-10,857 | $-10,192 |
| Beginning Cash Position | 137,636 | 137,636 | 137,636 | 298,395 | 298,395 |
| End Cash Position | 442,331 | 375,693 | 310,411 | 137,636 | 120,971 |
| Net Cash Flow | $304,695 | $238,057 | $172,775 | $-160,759 | $-177,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | 168,931 | 96,060 | 31,925 | 143,600 | 87,952 |
| Capital Expenditure | -468 | -209 | -199 | -231 | -138 |
| Free Cash Flow | 168,463 | 95,851 | 31,726 | 143,369 | 87,814 |